Atlas Trials

Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

Clinical trial NCT05736367 · RECRUITING

Trial details

NCT number
NCT05736367
Sponsor
Rutgers, The State University of New Jersey
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-11-15
Primary completion
2026-06-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.